Eledon Pharmaceuticals (ELDN) Other Accumulated Expenses (2013 - 2026)
Eledon Pharmaceuticals posted quarterly Other Accumulated Expenses of $55000.0 for Q1 2026, down 31.25% year-on-year from $80000.0 in Q1 2025, and down 91.3% on a QoQ basis from $632000.0 in Q4 2025.
Eledon Pharmaceuticals (ELDN) has 14 years of Other Accumulated Expenses data on file, last reported at $55000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Accumulated Expenses fell 31.25% year-over-year to $55000.0; the trailing twelve-month figure through Mar 2026 stood at $55000.0 (down 31.25% YoY), and the FY2025 full-year result was $632000.0, up 1244.68% from the prior year.
- Other Accumulated Expenses for Q1 2026 stood at $55000.0, down from $632000.0 in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $705000.0 in Q2 2024 and bottomed at $13000.0 in Q2 2022.
- The 5-year median for Other Accumulated Expenses is $50000.0 (2023), against an average of $127176.5.
- The widest annual swing landed in 2024, when Other Accumulated Expenses surged 1755.26%; it then tumbled 95.89% in 2025.
- A 5-year view of Other Accumulated Expenses shows it stood at $112000.0 in 2022, then tumbled by 60.71% to $44000.0 in 2023, then increased by 6.82% to $47000.0 in 2024, then surged by 1244.68% to $632000.0 in 2025, then plunged by 91.3% to $55000.0 in 2026.
- The last three Other Accumulated Expenses figures came in at $55000.0 (Q1 2026), $632000.0 (Q4 2025), and $52000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Eledon Pharmaceuticals | 419.90 Mn | 203.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 55,000.00 |
| Dec 31, 2025 | 632,000.00 |
| Sep 30, 2025 | 52,000.00 |
| Jun 30, 2025 | 29,000.00 |
| Mar 31, 2025 | 80,000.00 |
| Dec 31, 2024 | 47,000.00 |
| Sep 30, 2024 | 108,000.00 |
| Jun 30, 2024 | 705,000.00 |
| Mar 31, 2024 | 50,000.00 |
| Dec 31, 2023 | 44,000.00 |
| Sep 30, 2023 | 67,000.00 |
| Jun 30, 2023 | 38,000.00 |
| Mar 31, 2023 | 50,000.00 |
| Dec 31, 2022 | 112,000.00 |
| Sep 30, 2022 | 49,000.00 |
| Jun 30, 2022 | 13,000.00 |
| Mar 31, 2022 | 31,000.00 |
| Dec 31, 2021 | 83,000.00 |
| Sep 30, 2021 | 39,000.00 |
| Jun 30, 2021 | 17,000.00 |
| Mar 31, 2021 | 52,000.00 |
| Dec 31, 2020 | 146,000.00 |
| Sep 30, 2020 | 166,000.00 |
| Jun 30, 2020 | 9,000.00 |
| Mar 31, 2020 | 25,000.00 |
| Dec 31, 2019 | 7,000.00 |
| Sep 30, 2019 | 29,000.00 |
| Jun 30, 2019 | 16,000.00 |
| Mar 31, 2019 | 64,000.00 |
| Dec 31, 2018 | 14,000.00 |
| Sep 30, 2018 | 90,000.00 |
| Jun 30, 2018 | 224,000.00 |
| Mar 31, 2018 | 428,000.00 |
| Dec 31, 2017 | 668,000.00 |
| Sep 30, 2017 | 963,000.00 |
| Jun 30, 2017 | 1.30 Mn |
| Mar 31, 2017 | 229,000.00 |
| Dec 31, 2016 | 12,000.00 |
| Sep 30, 2016 | 114,000.00 |
| Jun 30, 2016 | 63,000.00 |
| Mar 31, 2016 | 79,000.00 |
| Dec 31, 2015 | 167,000.00 |
| Sep 30, 2015 | 105,000.00 |
| Jun 30, 2015 | 144,000.00 |
| Mar 31, 2015 | 100,000.00 |
| Dec 31, 2014 | 165,000.00 |
| Sep 30, 2014 | 187,000.00 |
| Dec 31, 2013 | 60,000.00 |